Evidence map›Paper›PMID 19453194›Full record

ArticleJournal of the American Chemical Society2009

Atomic-level mapping of antibody epitopes on a GPCR.

Cheryl Paes, Jada Ingalls, Karan Kampani, Chidananda Sulli, Esha Kakkar, Meredith Murray, Valery Kotelnikov, Tiffani A Greene, Joseph B Rucker, Benjamin J Doranz

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Signal transmission through the CXC chemokine receptor 4 (CXCR4) transmembrane helices.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Cheryl PaesIntegral Molecular, Inc., 3701 Market Street, Fourth Floor, Philadelphia, Pennsylvania 19104, USA.
Jada Ingalls
Karan Kampani
Chidananda Sulli
Esha Kakkar
Meredith Murray
Valery Kotelnikov
Tiffani A Greene
Joseph B Rucker
Benjamin J Doranz
Integral Molecular (United States) · US

Funding

A Tool for Modeling the Structure-Activity of Chemokine Receptors and Other GPCRsR44GM076779 · NIGMS · INTEGRAL MOLECULAR · PI DORANZ, BENJAMIN J · 2007 to 2009
$2.2M
Modeling the Structure-Activity of Chemokine ReceptorsR43GM076779 · NIGMS · INTEGRAL MOLECULAR · PI DORANZ, BENJAMIN JACOB · 2006 to 2006
$222k
NIGMS NIH HHS GM076779NIGMS NIH HHS R43 GM076779NIGMS NIH HHS R44 GM076779
6 · The paper itself

Abstract

Epitopes that define the immunodominant regions of conformationally complex integral membrane proteins have been difficult to reliably delineate. Here, a high-throughput approach termed shotgun mutagenesis was used to map the binding epitopes of five different monoclonal antibodies targeting the GPCR CCR5. The amino acids, and in some cases the atoms, that comprise the critical contact points of each epitope were identified, defining the immunodominant structures of this GPCR and their physicochemistry.

Indexed as

Antibodies, MonoclonalEpitope MappingFluorescent Antibody TechniqueImmunodominant EpitopesModels, MolecularMutagenesisPolymerase Chain ReactionReceptors, CCR5Antibodies, MonoclonalImmunodominant EpitopesReceptors, CCR5

Identifiers

PMID19453194
PMCPMC2943208
OpenAlexW1976201060

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.